Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
2020 Sep 1:S0161-6420(20)30844-7
PubMed PMID: 26413751
specifically HDAC 1
and IL-2 potently suppresses renal cell carcinoma in murine model
It covalently binds to the cysteine 88 of ubiquitin receptor RPN13 in the 19S regulatory particle and inhibits proteasome function
Afuresertib HCl - CAS# 1047645-82-8 Catalog No.:M6857-2 2020 Sep 1:S0161-6420(20)30844-7Afuresertib HCl, CAS No. 1047645 82 8, also known as GSK2110183, is an orally bioavailable inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor GSK2110183 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K Akt signaling pathway is
US$ 464.14
US$ 2837.46
US$ 210.87
US$ 11.75
US$ 1626.47
US$ 25.00